2026-10-28 11:01:53 UTC#528082newconfirmednews
CRDF stock news
CRDF stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.
See the full wire9 wire items
2026-10-27 21:53:00 UTC#524635newconfirmednews
Cardiff Oncology CMO Roger Sidhu steps down; Leila Alland appointed as interim replacement
dow_jonesimportance 0.30trust 0.90Cardiff Oncology, Inc. -0.20Roger Sidhu -0.20Leila Alland +0.10+2 entities
2026-09-15 10:38:00 UTC#312975newconfirmednews
H.C. Wainwright & Co. sets $9.00 price target on Cardiff Oncology (CRDF)
2026-09-14 14:31:08 UTC#308070updateconfirmednews
Cardiff Oncology to launch Phase III onvansertib trial in RAS-mutated mCRC following Nerviano settlement
quartrimportance 0.50trust 0.70Cardiff Oncology, Inc. +0.50Nerviano Medical Sciences S.r.l. +0.30onvansertib +0.50
2026-09-14 12:30:00 UTC#307275newconfirmedpress release
Cardiff Oncology and Nerviano Medical Sciences settle litigation and amend onvansertib license agreement
globenewswireimportance 0.50trust 1.00Cardiff Oncology, Inc. +0.40Nerviano Medical Sciences S.r.l. +0.40onvansertib +0.50+1 entities
2026-08-12 19:13:00 UTC#167220newconfirmednews
William Blair downgrades Cardiff Oncology (CRDF) to Market Perform from Outperform
2026-07-24 20:31:05 UTC#76948newconfirmednews
Cardiff Oncology (CRDF) Q2 2026 Earnings Preview: Analysts Expect $0.16 Loss Per Share and $70.71K Revenue
2026-07-16 12:43:01 UTC#40893updateconfirmednews
Cardiff Oncology prices $10.05M equity offering at $1.05 per share with H.C. Wainwright as placement agent
2026-07-15 12:13:32 UTC#35485newconfirmedpress release